临床生物标志物概况揭示了性差异和败血症死亡因素
Zhenglin Chang1,2, Jiancai Lu1, Qitai Zhang1
1State Key Laboratory of Respiratory Disease, Department of Clinical Laboratory, National Center for Respiratory Medicine, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
Frontiers in immunology
|June 5, 2024
概括
这项研究分析了败血症生物标志物,并发现性别之间存在明显的特征. 虽然败血症死亡率没有性别差异,但特定的生物标志物可以预测男性和女性的败血症进展和结果.
科学领域:
- 生物化学 生物化学
- 临床医学 临床医学
- 基因组学就是基因组学.
背景情况:
- 败血症仍然是全球主要的死亡原因,结果持续存在性别差异.
- 研究表明男性的败血症死亡率较高,需要进一步调查性别特异性因素.
研究的目的:
- 确定与败血症进展和死亡率相关的特定性别的临床生物标志物概况.
- 通过倾向性得分匹配,将败血症患者与年龄匹配的健康对照进行比较.
主要方法:
- 对265名败血症患者三年来的临床数据进行了回顾性分析.
- 利用主要组件分析 (PCA) 和接收器操作特征 (ROC) 分析进行生物标志物评估.
- 雇员倾向得分匹配选择年龄匹配的健康对照.
主要成果:
- 男人占败血症患者的比例更高 (60.8%);然而,死亡率与性别没有显著差异.
- 在已故和幸存的患者之间观察到年龄,高血压和SOFA分数的显著差异.
- 在败血症中确定了48个显著改变的血清生物标志物,其中Triiodothyronine,Apolipoprotein A和血清cystatin C显示出高诊断价值. 确定了特定于性别的生物标志物 (例如,男性的AFP,HDLC;女性的风湿性因子,IL-6) 和死亡预测因素 (例如,抗血,前白蛋白).
结论:
- 这些发现有助于更好地了解败血症中的性别差异,并可能指导未来的治疗策略.
- 需要进一步的研究来验证已识别的生物标志物配置文件,并探索毒症结果中性别差异的潜在分子机制.
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
137
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
137
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
77
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
77
01:20Comparing the Survival Analysis of Two or More Groups
177
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
177